Accelerating Cancer Research

Placing the patient at the center of cancer care

join us


Gateway for Cancer Research accelerates practice-changing discoveries in cancer care by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.

For Researchers

Explore Gateway’s cutting-edge cancer research program

Gateway Impact

Learn more about Gateway for Cancer Research and our critical mission

For Supporters

Donate to cancer research today and help advance lifesaving cancer research


Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.

Gateway’s Impact

More than 35,000 patients and families have been impacted by Gateway for Cancer Research funded clinical trials to date.


Patient Profile: John

Reflecting on the clinical trial, John says he wants others to know there is hope, and clinical trials are a big part of that hope.

Watch John’s Story

Why Give to Gateway

100% of all donations directly fund early phase clinical cancer research.

Get your Copy of GLOW Today!

Support Gateway for Cancer Research and get your free GLOW book today.

Find out how here

“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”

- Beth, lymphoma patient in a Gateway-funded trial

Gateway News

Gateway-funded pancreas cancer clinical trail at OSU expanding with drug manufacturer support.

Read More

Did You Know?

234 clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.

View Our Clinical Trials

Extraordinary Times Call for Extraordinary Measures

COVID-19 significantly disrupted patient access to clinical trials—research that can make a world of difference for those facing cancer. In response to this long-term trend, Gateway launched an innovative new funding program to support “decentralized” clinical studies that bring trials to the doorsteps of cancer patients by leveraging technology and at-home care.

Extraordinary Measures, an urgent new fundraising campaign unlike any we have ever conducted in our nearly 30-year history, will advance this new grant program, helping to ensure all those facing cancer continue to receive potentially lifesaving therapies.

Read More

Fund One Day

It costs just $19.62 per patient per day in a Gateway-funded cancer clinical trial.

Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniversary, birthday, wedding, bar/bat mitzvah or graduation.


Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.

Trial Type: Brain Cancer

RMC-5552 in Adults with Recurrent Glioblastoma

Nicholas Butowski, MD
University of California, San Francisco

Read More

Trial Type: Blood Cancer

Phase I Study of EZH2 Inhibitor Tulmimetostat in Cutaneous T-cell Lymphoma

Neha Metha Shah, MD, MSCI
Washington University School of Medicine

Read More